ENDE

Account

Overview · Filed: —

UPC_APP_11680/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsWithdrawal ApplicationsMunich LDApplication Rop 265—

Overview Decisions Documents Timeline

Parties

Claimants

Sanofi Mature IP(Sanofi Group)
Sanofi Winthrop Industrie(Sanofi Group)
Sanofi-Aventis France(Sanofi Group)
Sanofi-Aventis GmbH(Sanofi Group)
Sanofi Belgium(Sanofi Group)
Sanofi-Aventis Deutschland GmbH(Sanofi Group)
Sanofi S.r.l.(Sanofi Group)
Sanofi B.V.(Sanofi Group)
Sanofi - Produtos Farmaceuticos Lda(Sanofi Group)
Sanofi AB(Sanofi Group)
Sanofi A/S(Sanofi Group)

Reps: Frédéric Chevallier (Herbert Smith Freehills)

Respondents

STADAPHARM GmbH
STADA Arzneimittel AG
STADA Nordic ApS
Medac Gesellschaft für klinische Spezialpräparate m.b.H.

Reps: Daniel Hoppe (Preu Bohlig); Alexander Eisenführ (Uexkull + Stolberg)

Judges

Matthias ZigannPresiding Judge / Judge-Rapporteur
Alima ZanaLegally Qualified Judge
Tobias PichlmaierLegally Qualified Judge
Carola WagnerTechnically Qualified Judge

Patents

EP 2 493 466

CPC codes: A61K38/193, A61K31/573, A61P35/04, A61K31/164, A61K31/56, A61P43/00, A61P13/08, A61P15/00, A61K31/337, A61P35/00, A61K45/06, A61P25/16

Sector: Pharmaceutical & Medical

Outcome

Procedural only

Filed: —

First decided: Mar 19, 2025

Language: —